Theratechnologies Inc.
THTX
$2.77
-$0.05-1.77%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 102.61% | -186.86% | 514.34% | 109.86% | 57.09% |
| Total Depreciation and Amortization | -5.03% | -14.41% | -43.66% | 35.41% | -44.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.44% | 217.78% | 134.48% | -58.11% | -78.05% |
| Change in Net Operating Assets | -958.62% | 25.48% | -91.76% | -162.59% | -39.81% |
| Cash from Operations | -470.49% | 94.47% | -13.60% | 91.86% | 48.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,248.51% | 16.90% | 35.95% | -116.81% | 228.85% |
| Cash from Investing | -5,250.75% | 16.90% | 39.61% | -118.66% | 141.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -56.56% | -53,131.93% | 93.46% | -27.08% | 2.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.88% | 81.57% | 81.43% | -254.11% | -313.51% |
| Cash from Financing | 1,796.36% | -181.00% | 76.40% | -164.05% | -69.75% |
| Foreign Exchange rate Adjustments | -62.50% | -1,350.00% | -75.00% | -300.00% | -33.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -545.88% | -198.22% | 277.00% | 64.97% | 51.55% |